ArticleJournal of cancer research and clinical oncology2023

Predictive role of galectin-3 for immune checkpoint blockades (ICBs) in advanced or metastatic non-small cell lung cancer: a potential new marker for ICB resistance.

Jung Sun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.